Correction: GPR119 agonist enhances gefitinib responsiveness through lactate-mediatedinhibition of autophagy
J Exp Clin Cancer Res
.
2022 May 17;41(1):176.
doi: 10.1186/s13046-022-02388-0.
Authors
Ji Hye Im
1
,
Keon Wook Kang
2
,
Sun Young Kim
3
,
Yoon Gyoon Kim
3
,
Yong Jin An
4
,
Sunghyouk Park
4
,
Byung Hwa Jung
5
,
Song-Yi Choi
6
,
Jin-Sun Lee
6
,
Keon Wook Kang
7
Affiliations
1
College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.
2
Department of Nuclear Medicine, College of Medicine, Seoul National University, Seoul, Republic of Korea.
3
College of Pharmacy, Dankook University, Cheonan-si, Republic of Korea.
4
Natural Product Research Institute, College of Pharmacy, Seoul National University, Seoul, Republic of Korea.
5
Molecular Recognition Research Center, Korea Institute of Science and Technology, Seoul, Republic of Korea.
6
College of Medicine, Chungnam National University, Daejeon, Republic of Korea.
7
College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea. kwkang@snu.ac.kr.
PMID:
35581622
PMCID:
PMC9112569
DOI:
10.1186/s13046-022-02388-0
No abstract available
Publication types
Published Erratum